Scientists test if damaged livers change drug power
NCT ID NCT07023354
Summary
This early-stage study aims to understand how liver problems affect how much of a new drug, BI 1291583, gets into a person's bloodstream. The drug is being developed to treat bronchiectasis, a chronic lung disease. Researchers will compare blood levels in 32 adults with varying degrees of liver impairment to those with healthy livers after all take a single dose.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
American Research Corporation at the Texas Liver Institute
RECRUITINGSan Antonio, Texas, 78215, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Orlando Clinical Research Center
RECRUITINGOrlando, Florida, 32809, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Tranquil Clinical Research
COMPLETEDHouston, Texas, 77598, United States
Conditions
Explore the condition pages connected to this study.